Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-Based Differences in Atrial Fibrillation: Epidemiology, Prehospital Care, Hospital Management, and Outcomes.

Journal of the American Heart Association·2026
Same author

Temporal improvements in prehospital systems-of-care for ST-elevation myocardial infarction patients in Victoria, Australia: a retrospective study.

BMC emergency medicine·2026
Same author

Reply to: Sex-specific effects of manual pressure augmentation during defibrillation: a mechanistic hypothesis.

Resuscitation·2026
Same author

Machine Learning Prediction of Heart Failure Readmissions: Insights From a Multicenter Emergency Department Trial.

JACC. Advances·2026
Same author

Public versus private hospital pathways after emergency medical services transport for atrial fibrillation: a population-based cohort study.

Heart (British Cardiac Society)·2026
Same author

Aortic Stenosis and Heart Failure With Preserved Ejection Fraction: A Cautionary Tale of Common Partners.

Circulation. Heart failure·2026

Related Experiment Video

Updated: Jun 17, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K

Routine Protamine Administration for Bleeding in Transcatheter Aortic Valve Implantation: The ACE-PROTAVI Randomized

Pieter A Vriesendorp1,2,3, Shane Nanayakkara1,4,5, Samuel Heuts3,6

  • 1Heart Centre, The Alfred Hospital, Melbourne, Australia.

JAMA Cardiology
|August 14, 2024
PubMed
Summary

Routine protamine administration after transfemoral transcatheter aortic valve implantation (TAVI) improves hemostasis success and reduces vascular complications. This study found protamine administration safe and effective in TAVI patients.

More Related Videos

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

3.0K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 17, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K
Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

3.0K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.2K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Vascular complications are a significant concern following transfemoral transcatheter aortic valve implantation (TAVI).
  • Current data on the routine use of protamine to reverse anticoagulation post-TAVI are limited.

Purpose of the Study:

  • To assess the efficacy and safety of routine protamine administration after transfemoral TAVI.
  • To determine if protamine reduces procedure-related morbidity.

Main Methods:

  • The ACE-PROTAVI trial was a double-blind, placebo-controlled randomized clinical trial.
  • 410 patients undergoing transfemoral TAVI were randomized to receive either routine protamine or placebo.
  • Coprimary outcomes included hemostasis success rate and time to hemostasis (TTH).

Main Results:

  • Routine protamine administration led to a higher rate of hemostasis success (97.9% vs 91.6%) and shorter TTH (181s vs 279s).
  • The protamine group showed a reduced risk of a composite outcome including death and complications (5.2% vs 12.8%), primarily due to fewer minor vascular complications.
  • No adverse events were associated with protamine use.

Conclusions:

  • Routine protamine administration post-transfemoral TAVI enhances hemostasis success and reduces TTH.
  • Protamine use is associated with fewer vascular complications, shorter procedure times, and reduced hospital stays.
  • The ACE-PROTAVI trial demonstrates the safety and benefit of routine protamine in TAVI procedures.